Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals
Open Access
- 10 February 2009
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 9 (1), 15-9
- https://doi.org/10.1186/1471-2334-9-15
Abstract
BACKGROUND: A new generation of diagnostic tests, the interferon-γ release assays (IGRAs), have been developed for the detection of latent tuberculosis infection (LTBI). Limited data are available on their use in HIV-infected persons. METHODS: A cross-sectional study was carried out at 2 HIV clinics in Atlanta to assess the utility of two IGRA tests (T-SPOT.TB [TSPOT] and QuantiFERON-TB Gold in Tube [QFT-3G]) compared to the tuberculin skin test (TST). RESULTS: 336 HIV-infected persons were enrolled. Median CD4 count was 335 cells/μl and median HIV viral load was 400 copies/ml. Overall, 27 patients (8.0%) had at least 1 positive diagnostic test for LTBI: 7 (2.1%) had a positive TST; 9 (2.7%) a positive QFT-3G; and 14 (4.2%) a positive TSPOT. Agreement between the 3 diagnostic tests was poor: TST and TSPOT, [κ = 0.16, 95% CI (-0.06, 0.39)], TST and QFT-3G [κ = 0.23, 95% CI (-0.05, 0.51)], QFT-3G and TSPOT [κ = 0.06, 95% CI (-0.1, 0.2)]. An indeterminate test result occurred among 6 (1.8%) of QFT-3G and 47 (14%) of TSPOT tests. In multivariate analysis, patients with a CD4 ≤ 200 cells/μl were significantly more likely to have an indeterminate result [OR = 3.6, 95% CI (1.9, 6.8)]. CONCLUSION: We found a low prevalence of LTBI and poor concordance between all 3 diagnostic tests. Indeterminate test results were more likely at CD4 counts ≤ 200 cells/μl. Additional studies among HIV-infected populations with a high prevalence of TB are needed to further assess the utility of IGRAs in this patient population.Keywords
This publication has 25 references indexed in Scilit:
- Sensitivity of IFN-γ Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS ProgressionPLOS ONE, 2008
- Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected IndividualsAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for ResearchAnnals of Internal Medicine, 2007
- Effect of HIV-1 Infection on T-Cell–based and Skin Test Detection of Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Update on the Treatment of Tuberculosis and Latent Tuberculosis InfectionPublished by American Medical Association (AMA) ,2005
- Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic reviewThe Lancet Infectious Diseases, 2004
- Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapyAIDS, 2003
- Correlates of Protective Immunity to Mycobacterium tuberculosis in HumansClinical Infectious Diseases, 2000
- Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infectionThe Lancet, 1993
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989